Patent experts say few drugmakers are challenging frivolous drug patents and the Indian patent office is actually liberal in granting paten...

BDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib

Pfizer said US lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence provisions.

Indian shares are expected to trade in a range with a negative bias. Here is a list of twelve stocks that are likely to be in action today.

Pfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...

The finance ministry is understood to be also considering hiking the weighted deduction on expenditure on R&D) by drug companies to 200% fr...

Markets are expected to be under pressure on Monday tracking sluggish cues from global markets.

The government will not invoke CL unless the country is faced with an epidemic-like situation.

The Delhi HC rejected an injunction plea by Swiss drug major Roche to prevent Cipla from manufacturing generic versions of anti-cancer drug...